Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia - Hoffmann, Verena Sophia; Hehlmann, Rüdiger (Journal of cancer research and clinical oncology, 2017)
Gesehen am 28.05.2018